Biofarm Estimates RON325M Revenue In 2023, Up 17% From 2022

04.10.2023 By Ecaterina Craciun

Pharmaceutical producer Biofarm Bucuresti (BIO.RO), the fifth largest drug producer in Romania, has budgeted revenue of RON325 million for 2023, which translates into a 17% increase compared to the 2022 level, as per the budget of revenue and expenditure proposed by the company for 2023.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: Biofarm; , earnings

Comment

Username:
Password: